Nifty

:

25585.30

Sensex

:

83467.66

261.75 (1.03%)
862.23 (1.04%)

Login

Nifty
Sensex

:
:

25585.30
83467.66

261.75 (1.03%)
862.23 (1.04%)

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

Rating :

56/99

BSE: 539872 | NSE: BAJAJHCARE

Watchlist

NSE BSE

456.60

15-Oct-2025

Open
High
Low
Previous Close

461.65
461.9
455.25
462.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

74647
34196923.25
745
333.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,442.09
30.63
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,660.26
0.22%
3.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.48
-3.75
-5.64

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.64
-9.55
-5.83

PAT CAGR (%)

10 Years
5 Years
3 Years

18.00
-12.38
-12.25

P:E (Median)

8 Years
5 Years
3 Years

16.24
14.23
18.11

P:BV (Average)

8 Years
5 Years
3 Years

3.43
3.37
3.18

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.51
12.47
15.12

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 148.84 132.25 12.54% 154.47 133.90 15.36% 122.79 108.57 13.10% 133.09 101.21 31.50%
Expenses 124.33 107.74 15.40% 142.72 117.87 21.08% 101.15 89.04 13.60% 108.57 82.26 31.98%
EBITDA 24.51 24.50 0.04% 11.76 16.03 -26.64% 21.64 19.54 10.75% 24.52 18.95 29.39%
EBIDTM 16.47% 18.53% 7.61% 11.97% 17.62% 17.99% 18.43% 18.72%
Other Income 0.88 0.85 3.53% 13.57 6.45 110.39% 2.37 0.80 196.25% 2.61 1.22 113.93%
Interest 5.23 8.44 -38.03% 6.08 6.01 1.16% 5.51 6.65 -17.14% 7.88 8.26 -4.60%
Depreciation 5.64 6.73 -16.20% 7.53 7.30 3.15% 6.85 7.35 -6.80% 6.81 6.66 2.25%
PBT 14.53 10.18 42.73% 11.72 -35.15 - 11.65 6.33 84.04% 12.45 5.24 137.60%
Tax 2.35 2.16 8.80% 0.13 -3.15 - -3.31 0.80 - 4.10 0.12 3,316.67%
PAT 12.18 8.03 51.68% 11.59 -32.00 - 14.97 5.52 171.20% 8.34 5.12 62.89%
PATM 8.18% 6.07% 7.50% -23.90% 12.19% 5.09% 6.27% 5.06%
EPS 3.85 2.54 51.57% 3.67 -10.13 - 4.74 1.75 170.86% 2.64 1.62 62.96%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 559.19 542.60 473.42 645.80 679.89 656.98 410.01 325.02 289.51 207.24 200.23 Net Sales Growth 17.49% 14.61% -26.69% -5.01% 3.49% 60.24% 26.15% 12.27% 39.70% 3.50% Cost Of Goods Sold 301.45 286.45 254.77 382.78 406.14 377.89 263.23 196.87 177.68 111.23 105.65 Gross Profit 257.74 256.16 218.65 263.01 273.75 279.09 146.78 128.15 111.83 96.01 94.57 GP Margin 46.09% 47.21% 46.19% 40.73% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% 47.23% Total Expenditure 476.77 460.03 397.08 534.32 561.23 520.62 361.73 282.09 250.08 176.40 170.18 Power & Fuel Cost - 22.77 31.47 37.69 31.83 24.96 24.24 21.83 19.81 16.79 14.12 % Of Sales - 4.20% 6.65% 5.84% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% 7.05% Employee Cost - 57.06 43.85 42.32 41.11 34.55 28.18 24.62 21.65 19.57 16.93 % Of Sales - 10.52% 9.26% 6.55% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% 8.46% Manufacturing Exp. - 59.37 38.89 34.11 59.68 64.02 28.56 25.07 21.53 19.89 23.16 % Of Sales - 10.94% 8.21% 5.28% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% 11.57% General & Admin Exp. - 12.30 10.55 11.08 12.74 11.03 7.95 6.64 5.06 5.76 5.87 % Of Sales - 2.27% 2.23% 1.72% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% 2.93% Selling & Distn. Exp. - 18.90 14.57 19.09 3.91 4.17 1.28 1.77 1.64 1.26 1.17 % Of Sales - 3.48% 3.08% 2.96% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% 0.58% Miscellaneous Exp. - 3.17 2.99 7.25 5.81 4.00 8.28 5.29 2.70 1.90 1.17 % Of Sales - 0.58% 0.63% 1.12% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% 1.64% EBITDA 82.43 82.57 76.34 111.48 118.66 136.36 48.28 42.93 39.43 30.84 30.05 EBITDA Margin 14.74% 15.22% 16.13% 17.26% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% 15.01% Other Income 19.43 19.40 8.69 1.59 1.44 6.91 6.53 0.97 2.07 2.39 0.38 Interest 24.70 28.06 29.75 17.68 12.78 8.34 6.63 8.32 7.73 8.20 7.64 Depreciation 26.83 27.92 27.62 17.21 17.64 16.12 12.12 11.41 11.08 11.35 9.29 PBT 50.35 46.01 27.65 78.18 89.68 118.82 36.06 24.17 22.68 13.69 13.50 Tax 3.27 3.08 -2.35 14.65 18.30 35.71 10.82 7.86 7.50 5.87 5.30 Tax Rate 6.49% 6.69% 14.09% 18.74% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% 39.26% PAT 47.08 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 PAT before Minority Interest 47.08 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.42% 7.91% -3.03% 9.84% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% 4.10% PAT Growth 453.19% - - -11.01% -14.10% 229.28% 54.75% 7.37% 94.25% -4.63% EPS 14.90 13.59 -4.53 20.10 22.59 26.30 7.99 5.16 4.81 2.47 2.59

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 466.16 278.36 367.69 328.49 258.41 177.93 129.11 113.61 99.00 88.63 Share Capital 15.79 13.80 13.80 13.80 13.80 13.80 6.90 6.90 6.90 6.75 Total Reserves 432.80 264.56 353.89 314.69 244.61 164.13 122.21 106.71 92.10 81.88 Non-Current Liabilities 51.00 23.43 96.37 70.54 84.65 27.40 20.41 23.45 27.69 32.26 Secured Loans 64.67 38.58 93.66 66.31 79.71 22.97 16.19 19.80 24.41 27.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.60 1.20 1.68 2.43 4.00 Long Term Provisions 4.98 6.14 1.45 2.67 2.78 2.08 1.42 0.77 0.00 0.00 Current Liabilities 272.27 402.11 435.23 322.07 182.57 137.61 117.34 131.07 92.55 88.13 Trade Payables 95.47 89.43 84.75 104.92 68.95 57.48 29.98 43.38 18.85 16.17 Other Current Liabilities 41.69 51.07 47.55 31.44 24.98 21.18 25.62 25.93 20.02 20.06 Short Term Borrowings 133.84 261.48 289.42 176.20 88.47 58.43 54.89 54.52 39.16 42.29 Short Term Provisions 1.26 0.12 13.51 9.51 0.18 0.52 6.84 7.25 14.52 9.60 Total Liabilities 789.43 703.90 899.29 721.10 525.63 342.94 266.86 268.13 219.24 209.02 Net Block 238.45 252.75 365.69 269.74 208.13 162.24 128.50 126.62 127.93 129.56 Gross Block 436.47 422.98 525.01 401.73 329.25 267.83 222.23 209.65 199.88 191.39 Accumulated Depreciation 198.02 170.23 159.32 131.99 121.13 105.59 93.74 83.03 71.95 61.83 Non Current Assets 253.24 263.22 397.26 322.79 267.30 174.53 129.68 128.59 128.16 131.02 Capital Work in Progress 3.45 6.62 21.73 51.98 57.05 5.45 1.18 1.97 0.23 1.46 Non Current Investment 0.00 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.73 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 5.61 2.70 9.84 1.07 2.12 1.84 0.00 0.00 0.00 0.00 Current Assets 485.40 404.54 502.04 398.31 258.33 168.42 137.17 139.55 91.08 78.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 161.89 144.04 208.79 159.26 97.11 39.28 30.05 33.66 16.76 19.64 Sundry Debtors 251.67 180.24 194.17 184.51 98.88 98.48 78.13 80.38 52.69 42.95 Cash & Bank 4.45 2.93 19.23 1.98 14.24 4.16 7.86 8.29 0.84 0.36 Other Current Assets 67.39 37.28 35.58 37.59 48.10 26.50 21.13 17.21 20.79 15.04 Short Term Loans & Adv. 31.90 40.06 44.27 14.97 16.10 13.13 18.79 14.98 18.19 12.84 Net Current Assets 213.14 2.43 66.80 76.24 75.76 30.80 19.83 8.47 -1.47 -10.13 Total Assets 738.64 667.76 899.30 721.10 525.63 342.95 266.85 268.14 219.24 209.02

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 21.62 92.29 -22.19 0.69 43.56 20.57 25.17 16.61 22.12 25.14 PBT 42.00 -103.87 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 Adjustment 46.42 169.79 55.89 31.47 24.48 15.54 20.06 18.77 19.32 16.83 Changes in Working Capital -62.21 39.15 -124.76 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 -0.31 Cash after chg. in Working capital 26.21 105.08 -10.66 10.32 79.21 29.70 38.19 22.58 27.20 30.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.59 -12.79 -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 -4.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -14.82 -11.24 -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 -30.67 Net Fixed Assets -10.32 117.14 -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 -29.87 Net Investments 0.00 0.00 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 0.00 Others -4.50 -128.38 -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 -0.80 Cash from Financing Activity -6.38 -96.60 131.37 61.85 75.46 3.28 -12.57 2.47 -13.20 5.08 Net Cash Inflow / Outflow 0.43 -15.55 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 -0.44 Opening Cash & Equivalents 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 Closing Cash & Equivalent 2.60 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.42

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 142.04 100.86 133.23 119.02 93.63 64.47 64.41 52.73 71.74 34.33 ROA 5.51% -1.74% 7.84% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% 4.12% ROE 11.81% -4.44% 18.25% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% 19.60% ROCE 11.40% 1.88% 14.02% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% 18.00% Fixed Asset Turnover 1.26 1.00 2.79 1.86 2.20 1.67 1.71 1.60 1.18 1.26 Receivable days 145.27 144.33 53.51 76.07 54.82 78.61 78.15 74.24 75.67 77.37 Inventory Days 102.90 136.01 52.00 68.82 37.89 30.86 31.41 28.13 28.80 30.89 Payable days 117.80 124.77 90.43 78.13 61.06 43.87 46.86 44.67 35.97 41.39 Cash Conversion Cycle 130.36 155.57 15.08 66.76 31.65 65.59 62.70 57.71 68.50 66.87 Total Debt/Equity 0.50 1.19 1.13 0.78 0.70 0.51 0.91 1.19 0.76 1.75 Interest Cover 2.64 0.44 5.42 8.02 15.25 6.44 3.91 3.93 2.67 2.77

Top Investors:

vanaja sundar iyer

weststone management consultancy pvt ltd

hdfc mutual fund - hdfc pharma and healthcare fund

Annual Reports:

News Update:

Bajaj Healthcare secures SEC-CDSCO nod for Phase III Clinical Trials of Suvorexant Tablets
4th Oct 2025, 16:30 PM

The company is the first company in India to receive this regulatory nod for Suvorexant
Read More
Bajaj Healthcare - Quarterly Results
28th Jul 2025, 18:41 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback